Amicus Therapeutics upgraded by SVB Leerink with a new price target
$FOLD
Biotechnology: Pharmaceutical Preparations
Health Care
SVB Leerink upgraded Amicus Therapeutics from Market Perform to Outperform and set a new price target of $16.00 from $12.00 previously